Beta Bionics, Inc.

We market and distribute the iLet in the United States through a direct commercial organization that includes sales, clinical, and customer support teams. Our commercial focus is centered on endocrinology practices that manage a high concentration of people using intensive insulin therapy, with plans to broaden over time into primary care practices that manage an estimated half of the T1D population. When we are not contracted with a specific health plan for direct fulfillment, we utilize independent distributors to support order processing, benefits investigation, and product delivery.

Our customer-facing infrastructure is designed to support onboarding, training, and long-term retention. We provide comprehensive education programs for patients and healthcare professionals, delivered through certified trainers, virtual resources, and digital tools. Our customer support team provides continuous technical assistance, order support, and product guidance throughout the life of the device. We also engage users, caregivers, and clinicians through community-focused initiatives such as the Bionic Universe, which helps share real-world experiences and informs future product refinements. This integrated commercial, training, and support model is intended to ensure a high quality user experience and strengthen long-term customer loyalty.